Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsTarsonsproducts

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Exit Marksans Pharma, says Vijay Chopra

      Vijay Chopra of enochventures.com is of the view that one may exit Marksans Pharma.

    • Sell Marksans Pharma on rise: Nooresh Merani

      Nooresh Merani of Asian Market Securities suggests selling Marksans Pharma on rise.

    • Hold Marksans Pharma, says CA Rudramurthy BV

      CA Rudramurthy BV of Vachana Investments is of the view that one may hold Marksans Pharma.

    • Bull's Eye: Buy India Cements, Colgate, Voltas; sell LIC Housing

      Jay Thakkar of Sharekhan is of the view that one may sell Apollo Hospital with a target of Rs 1331.

    • Exit Marksans Pharma at around Rs 55-56: SP Tulsian

      SP Tulsian of sptulsian.com is of the view that one may exit Marksans Pharma at around Rs 55-56.

    • Prefer Jet Airways from aviation space: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one may prefer Jet Airways from the aviation space.

    • Ashok Leyland may test Rs 110-120: Vishal Malkan

      Vishal Malkan of malkansview.com is of the view that Ashok Leyland may test Rs 110-120.

    • Remain invested in Marksans Pharma: Ashu Madan

      According to Ashu Madan of Religare Securities, one may remain invested in Marksans Pharma.

    • Exit Marksans Pharma, advises SP Tulsian

      SP Tulsian of sptulsian.com recommends exiting Marksans Pharma.

    • Marksans Pharma may test Rs 58-60: Ambareesh Baliga

      Ambareesh Baliga, Independent Market Expert is of the view that Marksans Pharma may test Rs 58-60.

    • Here are top 10 stocks for today

      Here are top 10 stocks picked up by CNBC-TV18's analysts in trade today - IDBI Bank, Indiabulls Real Estate, Marksans Pharma, Marico, NBCC, Sun Pharma, Interglobe Aviation, Cadila, HDIL, Eros International, Godrej Properties and Raymond.

    • Bull's Eye: Buy JK Tyre, Eveready, Escorts, Hind Zinc

      Gaurav Ratnaparkhi of Sharekhan advises buying JK Tyre with a target of Rs 119.

    • Bull's Eye: Buy DLF, Wockhardt, GIC Housing, SAIL, NCC

      Manas Jaiswal of manasjaiswal.com recommends buying Firstsource Solutions with a target of Rs 47.50 and Indian Hotels with a target of Rs 120.

    • Hold Marksans Pharma; target Rs 110: CA Rudramurthy

      CA Rudramurthy BV of Vachana Investments advises holding Marksans Pharma as the stock may test Rs 110.

    • Buy Marksans Pharma, NOCIL: Nooresh Merani

      Nooresh Merani of Asian Market Securities recommends buying Marksans Pharma and NOCIL.

    • Bull's Eye: Buy Voltas, DLF; sell Ashok Leyland, Crompton

      Manish Sharma of Derivative Trading Research advises buying Voltas with a target of Rs 295.

    • Buy Marksans Pharma, Bajaj Finserve: Pritesh Mehta

      Pritesh Mehta of IIFL suggests buying Marksans Pharma and Bajaj Finserve.

    • Stay invested in Marksans Pharma, says Ashish Kyal

      Ashish Kyal of wavesstrategy.com is of the view that one may stay invested in Marksans Pharma for long term.

    • See 40-50% returns in Marksans Pharma: CK Narayan

      CK Narayan, MD, Growth Avenues Asset Advisors is of the view that one can see 40-50 percent return in Marksans Pharma.

    • Bull's Eye: DLF, JK Tyre, Ceat, AB Nuvo, GHCL, Dabur

      Jay Thakkar of Sharekhan advises buying Sterlite Technologies with a target of Rs 88.20.

    • Bull's Eye: Buy LIC Housing, Amara Raja, sell Wockhardt

      Manav Chopra of Networth Stock Broking advises buying LIC Housing Finance with a target of Rs 450.

    • Prefer Sun Pharma, ICICI Bank: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas Financial Services is of the view that one may prefer Sun Pharmaceuticals Industries and ICICI Bank.

    • Top buzzing midcap stocks to trade on August 10

      Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - PTC India Finance, MRPL, Vardhman Polytex, Divis Labs, GSPL, Ratnamani Metal, Marksans, Munjal Auto, SMS Pharma & Shakti Pumps.

    • Bull's Eye: Short DLF, Allahabad Bank, buy Tata Chem, LIC

      Pankaj Jain, Market Expert suggests buying Marksans Pharma with a target of Rs 103.

    • Prefer MphasiS, KPIT, Exide: Dilip Bhat

      Dilip Bhat of Prabhudas Lilladher is of the view that one may prefer MphasiS, KPIT Tech and Exide Industries.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347